HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway

HNF4α inhibits the malignancy of intrahepatic cholangiocarcinoma by suppressing the Wnt signaling pathway

Previous studies have demonstrated that intrahepatic cholangiocarcinoma (ICC) may derive from transdifferentiation of hepatocytes, so transforming ICC cells into hepatocytes could be a potential strategy for treating ICC. Hepatocyte nuclear factor 4α (HNF4α), a master transcription factor in the liv...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bo-Nan Xu, Cheng-Hong Ding, Yi-Long Liu, Yuan-Yuan Luo, Juan Deng, Shu-Qing Liu, Meng-Chao Xiao, Nan Jiang, Xin Zhang, Wen-Ping Xu, Wei-Fen Xie
Format:	Article
Language:	English
Published:	Elsevier 2025-03-01
Series:	Translational Oncology
Subjects:	Hepatocyte nuclear factor 4α (HNF4α) Intrahepatic cholangiocarcinoma (ICC) Wnt signaling pathway Isocitrate dehydrogenase 1(IDH1)
Online Access:	http://www.sciencedirect.com/science/article/pii/S193652332500021X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes
by: Hongchen Li, et al.
Published: (2025-06-01)

Impact of lymph node dissection on the prognosis of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
by: Jun Yu, et al.
Published: (2025-07-01)

Features of epileptiform activity in patients with diagnosed glioblastoma: from genetic and biochemical mechanisms to clinical aspects
by: E. E. Tyagunova, et al.
Published: (2022-12-01)

Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8‐AS1/GPX4 Axis in Intrahepatic Cholangiocarcinoma
by: Zhi‐Wen Chen, et al.
Published: (2025-08-01)

Application value of 18F-FDG PET/CT in soft tissue metastasis of intrahepatic cholangiocarcinoma: a case report and literature review
by: Siwen Liu, et al.
Published: (2025-01-01)

Quantitative benefit–risk assessment of data from the phase III ClarIDHy study of ivosidenib versus placebo in patients with mIDH1 cholangiocarcinoma
by: J.W. Valle, et al.
Published: (2025-06-01)

Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
by: Shanlin Li, et al.
Published: (2025-08-01)

Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma
by: Meng Sha, et al.
Published: (2018-09-01)

HNF4α contributes to hepatic CAR dysfunction in polymicrobial sepsis
by: Céline Van Dender, et al.
Published: (2025-08-01)

Identification of the Grapefruit (<i>Citrus paradisi</i>) Isocitrate Dehydrogenase Gene and Functional Analysis of <i>CpNADP-IDH1</i> in Citric Acid Metabolism
by: Longfei Jin, et al.
Published: (2025-05-01)

A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death
by: Céline Van Dender, et al.
Published: (2024-09-01)

Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma
by: Alexander S. Himstead, et al.
Published: (2025-01-01)

Hepatic arterial infusion chemotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a meta-analysis of survival outcomes
by: Di Zeng, et al.
Published: (2025-07-01)

Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
by: A. S. Makarova, et al.
Published: (2017-10-01)

Predictors of intrahepatic cholangiocarcinoma recurrence after surgical treatment
by: E. V. Kondratyev, et al.
Published: (2024-09-01)

Successful radical surgical resection of initially unresectable intrahepatic cholangiocarcinoma by downsizing chemotherapy with gemcitabine plus cisplatin: a case report
by: Ryosuke Takayanagi, et al.
Published: (2017-11-01)

Hepatic arterial infusion chemotherapy with Folfox 4 regimen versus cisplatin and gemcitabine for locally advanced intrahepatic cholangiocarcinoma
by: Lin Liu, et al.
Published: (2025-07-01)

IDH Mutant Cholangiocarcinoma: Pathogenesis, Management, and Future Therapies
by: Alexander Bray, et al.
Published: (2025-01-01)

A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach
by: Hongwei Qian, et al.
Published: (2025-03-01)

Cystatin B Promotes the Proliferation, Migration, and Invasion of Intrahepatic Cholangiocarcinoma
by: Dai Zhang, et al.
Published: (2025-01-01)

IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
by: Kristian A. Choate, et al.
Published: (2024-10-01)

Intrahepatic cholangiocarcinoma with a liver abscess due to hepatic actinomycosis
by: Tomoya Masuda, et al.
Published: (2023-03-01)

Distinct roles of Constitutive Photomorphogenesis Protein 1 homolog (COP1) in human hepatocyte models
by: Sébastien Soubeyrand, et al.
Published: (2025-02-01)

Current principles for the surgical treatment of intrahepatic cholangiocarcinoma
by: Catalin Savin, et al.
Published: (2024-10-01)

The hepatocyte nuclear factor 1 homeobox A (HNF1A) gene polymorphism and AFP serum levels in Egyptian HCC patients
by: Hanan M. Bedair, et al.
Published: (2024-12-01)

ERK1/2 Signaling in Intrahepatic Cholangiocarcinoma: From Preclinical Advances to Therapeutic Strategies
by: Veronica Porreca, et al.
Published: (2025-06-01)

Dual Role of HNF4α in Colorectal Adenocarcinoma During Carcinogenesis and Metastasis
by: Ju Seok Kim, et al.
Published: (2025-04-01)

Percutaneous Radio-frequency Assisted Liver Partition with Portal vein embolization in Staged liver resection (PRALPPS) in patients with perihilar and intrahepatic cholangiocarcinoma: evaluation of short-term results
by: O. V. Melekhina, et al.
Published: (2019-04-01)

Molecular genetic aspects of intrahepatic cholangiocarcinoma: literature review
by: B. N. Gurmikov, et al.
Published: (2019-04-01)

Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery
by: Takuya Yamamoto, et al.
Published: (2020-10-01)

Primary intrahepatic cholangiocarcinoma with sarcomatous stroma: case report and review of the literature
by: Kyohei Yugawa, et al.
Published: (2018-11-01)

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma
by: Katherine J. Crawford, et al.
Published: (2025-07-01)

Isocitrate Dehydrogenase-Wildtype Glioma Adapts Toward Mutant Phenotypes and Enhanced Therapy Sensitivity Under D-2-Hydroxyglutarate Exposure
by: Geraldine Rocha, et al.
Published: (2025-06-01)

Intrahepatic cholangiocarcinoma
by: A. B. Luk’yanchenko, et al.
Published: (2016-02-01)

Exploring the causal relationship between inflammatory cytokines and intrahepatic cholangiocarcinoma: a Mendelian randomization study
by: Yue Tang, et al.
Published: (2025-04-01)

Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma
by: Yoshitaka Shimamaki, et al.
Published: (2024-02-01)

Clinical and magnetic resonance imaging features predict microvascular invasion in intrahepatic cholangiocarcinoma
by: Jin-Jun Sun, et al.
Published: (2022-09-01)

Prognostic value of CRP–albumin–lymphocyte index in patients with intrahepatic cholangiocarcinoma after radical resection
by: Shi-Qian Lang, et al.
Published: (2025-03-01)

The Effect of FOXA3 Overexpression on Hepatocyte Differentiation and Liver Regeneration in a Fah cKO Mouse ModelSummary
by: Shao Li, et al.
Published: (2025-01-01)

Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinoma
by: Jinghan Zhu, et al.
Published: (2025-08-01)